Literature DB >> 28902771

Attention and Visual Motor Integration in Young Children with Uncorrected Hyperopia.

Marjean Taylor Kulp1, Elise Ciner, Maureen Maguire, Maxwell Pistilli, T Rowan Candy, Gui-Shuang Ying, Graham Quinn, Lynn Cyert, Bruce Moore.   

Abstract

SIGNIFICANCE: Among 4- and 5-year-old children, deficits in measures of attention, visual-motor integration (VMI) and visual perception (VP) are associated with moderate, uncorrected hyperopia (3 to 6 diopters [D]) accompanied by reduced near visual function (near visual acuity worse than 20/40 or stereoacuity worse than 240 seconds of arc).
PURPOSE: To compare attention, visual motor, and visual perceptual skills in uncorrected hyperopes and emmetropes attending preschool or kindergarten and evaluate their associations with visual function.
METHODS: Participants were 4 and 5 years of age with either hyperopia (≥3 to ≤6 D, astigmatism ≤1.5 D, anisometropia ≤1 D) or emmetropia (hyperopia ≤1 D; astigmatism, anisometropia, and myopia each <1 D), without amblyopia or strabismus. Examiners masked to refractive status administered tests of attention (sustained, receptive, and expressive), VMI, and VP. Binocular visual acuity, stereoacuity, and accommodative accuracy were also assessed at near. Analyses were adjusted for age, sex, race/ethnicity, and parent's/caregiver's education.
RESULTS: Two hundred forty-four hyperopes (mean, +3.8 ± [SD] 0.8 D) and 248 emmetropes (+0.5 ± 0.5 D) completed testing. Mean sustained attention score was worse in hyperopes compared with emmetropes (mean difference, -4.1; P < .001 for 3 to 6 D). Mean Receptive Attention score was worse in 4 to 6 D hyperopes compared with emmetropes (by -2.6, P = .01). Hyperopes with reduced near visual acuity (20/40 or worse) had worse scores than emmetropes (-6.4, P < .001 for sustained attention; -3.0, P = .004 for Receptive Attention; -0.7, P = .006 for VMI; -1.3, P = .008 for VP). Hyperopes with stereoacuity of 240 seconds of arc or worse scored significantly worse than emmetropes (-6.7, P < .001 for sustained attention; -3.4, P = .03 for Expressive Attention; -2.2, P = .03 for Receptive Attention; -0.7, P = .01 for VMI; -1.7, P < .001 for VP). Overall, hyperopes with better near visual function generally performed similarly to emmetropes.
CONCLUSIONS: Moderately hyperopic children were found to have deficits in measures of attention. Hyperopic children with reduced near visual function also had lower scores on VMI and VP than emmetropic children.

Entities:  

Mesh:

Year:  2017        PMID: 28902771      PMCID: PMC5656062          DOI: 10.1097/OPX.0000000000001123

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  18 in total

1.  Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol.

Authors:  P S Moke; A H Turpin; R W Beck; J M Holmes; M X Repka; E E Birch; R W Hertle; R T Kraker; J M Miller; C A Johnson
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

2.  Infant vision screening predicts failures on motor and cognitive tests up to school age.

Authors:  Janette Atkinson; Shirley Anker; Marko Nardini; Oliver Braddick; Claire Hughes; Sarah Rae; John Wattam-Bell; Sue Atkinson
Journal:  Strabismus       Date:  2002-09

3.  The accommodative lag of the young hyperopic patient.

Authors:  T Rowan Candy; Kathryn H Gray; Christy C Hohenbary; Don W Lyon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-17       Impact factor: 4.799

4.  Sensitivity of screening tests for detecting vision in preschoolers-targeted vision disorders when specificity is 94%.

Authors:  Gui-Shuang Ying; Marjean Taylor Kulp; Maureen Maguire; Elise Ciner; Lynn Cyert; Paulette Schmidt
Journal:  Optom Vis Sci       Date:  2005-05       Impact factor: 1.973

5.  Vision anomalies and reading skill: a meta-analysis of the literature.

Authors:  H D Simons; P A Gassler
Journal:  Am J Optom Physiol Opt       Date:  1988-11

6.  Educational attainment of 10-year-old children with treated and untreated visual defects.

Authors:  S Stewart-Brown; M N Haslum; N Butler
Journal:  Dev Med Child Neurol       Date:  1985-08       Impact factor: 5.449

7.  Prevalence of refractive error among preschool children in an urban population: the Baltimore Pediatric Eye Disease Study.

Authors:  Lydia Giordano; David S Friedman; Michael X Repka; Joanne Katz; Josephine Ibironke; Patricia Hawes; James M Tielsch
Journal:  Ophthalmology       Date:  2009-02-25       Impact factor: 12.079

8.  Minus lens stimulated accommodative lag as a function of age.

Authors:  Heather A Anderson; Adrian Glasser; Karla K Stuebing; Ruth E Manny
Journal:  Optom Vis Sci       Date:  2009-06       Impact factor: 1.973

9.  Uncorrected Hyperopia and Preschool Early Literacy: Results of the Vision in Preschoolers-Hyperopia in Preschoolers (VIP-HIP) Study.

Authors:  Marjean Taylor Kulp; Elise Ciner; Maureen Maguire; Bruce Moore; Jill Pentimonti; Maxwell Pistilli; Lynn Cyert; T Rowan Candy; Graham Quinn; Gui-Shuang Ying
Journal:  Ophthalmology       Date:  2016-01-27       Impact factor: 12.079

Review 10.  Infant hyperopia: detection, distribution, changes and correlates-outcomes from the cambridge infant screening programs.

Authors:  Janette Atkinson; Oliver Braddick; Marko Nardini; Shirley Anker
Journal:  Optom Vis Sci       Date:  2007-02       Impact factor: 1.973

View more
  2 in total

Review 1.  Vision Screening, Vision Disorders, and Impacts of Hyperopia in Young Children: Outcomes of the Vision in Preschoolers (VIP) and Vision in Preschoolers - Hyperopia in Preschoolers (VIP-HIP) Studies.

Authors:  Marjean Taylor Kulp; Elise Ciner; Gui-Shuang Ying; T Rowan Candy; Bruce D Moore; Deborah Orel-Bixler
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2022-01-18

2.  Evidence-based preschool-age vision screening: health policy considerations.

Authors:  Deena Rachel Zimmerman; Hadas Ben-Eli; Bruce Moore; Monique Toledano; Chen Stein-Zamir; Ariela Gordon-Shaag
Journal:  Isr J Health Policy Res       Date:  2019-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.